Chengda Ren

489 total citations
25 papers, 359 citations indexed

About

Chengda Ren is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Chengda Ren has authored 25 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Ophthalmology, 10 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Chengda Ren's work include Retinal Diseases and Treatments (11 papers), Glaucoma and retinal disorders (5 papers) and Retinal Development and Disorders (5 papers). Chengda Ren is often cited by papers focused on Retinal Diseases and Treatments (11 papers), Glaucoma and retinal disorders (5 papers) and Retinal Development and Disorders (5 papers). Chengda Ren collaborates with scholars based in China. Chengda Ren's co-authors include Jing Yu, Wenting Cai, Qingyu Liu, Donghui Yu, Tianyi Shen, Junling Liu, Ding Xu, Tingting Li, Qianyi Wang and Yan Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Science and Molecular Therapy.

In The Last Decade

Chengda Ren

22 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengda Ren China 12 135 126 103 74 73 25 359
Youn‐Shen Bee Taiwan 13 158 1.2× 65 0.5× 149 1.4× 42 0.6× 37 0.5× 33 427
Hiroki Tsujinaka Japan 11 160 1.2× 111 0.9× 86 0.8× 25 0.3× 37 0.5× 25 375
Huixia Wei China 13 96 0.7× 70 0.6× 87 0.8× 69 0.9× 25 0.3× 32 308
Yinghong Ji China 17 343 2.5× 172 1.4× 309 3.0× 125 1.7× 38 0.5× 38 699
Rayne R. Lim United States 11 174 1.3× 150 1.2× 235 2.3× 23 0.3× 91 1.2× 23 496
Kairan Lai China 12 186 1.4× 105 0.8× 142 1.4× 48 0.6× 86 1.2× 23 380
Baoshan Huang China 11 24 0.2× 56 0.4× 139 1.3× 133 1.8× 84 1.2× 16 395
Dongqing Zhu China 12 177 1.3× 150 1.2× 96 0.9× 47 0.6× 18 0.2× 32 355
Chang Rae Rho South Korea 12 173 1.3× 239 1.9× 75 0.7× 73 1.0× 139 1.9× 38 422
Tokuhiko Miki Japan 14 363 2.7× 152 1.2× 136 1.3× 71 1.0× 19 0.3× 53 663

Countries citing papers authored by Chengda Ren

Since Specialization
Citations

This map shows the geographic impact of Chengda Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengda Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengda Ren more than expected).

Fields of papers citing papers by Chengda Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengda Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengda Ren. The network helps show where Chengda Ren may publish in the future.

Co-authorship network of co-authors of Chengda Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Chengda Ren. A scholar is included among the top collaborators of Chengda Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengda Ren. Chengda Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Chaojun, Chengda Ren, Yan Wu, et al.. (2025). ZLN005, a PGC-1α agonist, delays photoreceptor degeneration by enhancing mitochondrial biogenesis in a murine model of retinitis pigmentosa. Neuropharmacology. 269. 110361–110361. 2 indexed citations
2.
Wu, Xiaoyi, Junwei Song, Qin Ye, et al.. (2025). Comparative evaluation of liver-directed knockin strategies with viral and nonviral vectors in mouse inherited disease models. Molecular Therapy. 34(3). 1775–1793.
3.
4.
Lin, Ruoyi, Chaojun Hu, Tianyi Shen, et al.. (2025). Egr1/Gc/vitamin transport axis mediates synergistic effect of macular thinning and underweight in age-related visual acuity decline. Experimental Eye Research. 258. 110525–110525.
5.
Wu, Yan, Tianyi Shen, Ruoyi Lin, et al.. (2024). Evaluation of inflammatory hyperreflective foci and plasma EPA as diagnostic and predictive markers for age-related macular degeneration. Frontiers in Neuroscience. 18. 1401101–1401101. 1 indexed citations
6.
Cai, Wenting, Yan Wu, Chengda Ren, et al.. (2024). Topical Application of Cell-Penetrating Peptide Modified Anti-VEGF Drug Alleviated Choroidal Neovascularization in Mice. International Journal of Nanomedicine. Volume 19. 35–51. 10 indexed citations
7.
Ren, Chengda, et al.. (2024). Melatonin protects RPE cells from necroptosis and NLRP3 activation via promoting SERCA2-related intracellular Ca2+ homeostasis.. Phytomedicine. 135. 156088–156088. 7 indexed citations
8.
Yu, Donghui, Wenting Cai, Tianyi Shen, et al.. (2023). PM2.5 exposure increases dry eye disease risks through corneal epithelial inflammation and mitochondrial dysfunctions. Cell Biology and Toxicology. 39(6). 2615–2630. 26 indexed citations
9.
Shen, Tianyi, Ruoyi Lin, Donghui Yu, et al.. (2023). Succinate-induced macrophage polarization and RBP4 secretion promote vascular sprouting in ocular neovascularization. Journal of Neuroinflammation. 20(1). 308–308. 14 indexed citations
10.
Li, Tingting, Yan Wu, Wenting Cai, et al.. (2022). Vision Defense: Efficient Antibacterial AIEgens Induced Early Immune Response for Bacterial Endophthalmitis. Advanced Science. 9(25). e2202485–e2202485. 43 indexed citations
11.
Ren, Chengda, Yan Wu, Tingting Li, et al.. (2022). Nicotinamide Mononucleotide Ameliorates Cellular Senescence and Inflammation Caused by Sodium Iodate in RPE. Oxidative Medicine and Cellular Longevity. 2022(1). 5961123–5961123. 20 indexed citations
12.
Ren, Chengda & Jing Yu. (2022). Potential gene identification and pathway crosstalk analysis of age-related macular degeneration. Frontiers in Genetics. 13. 992328–992328. 3 indexed citations
13.
Ren, Chengda, Wenting Cai, Donghui Yu, et al.. (2021). MicroRNA‐27a Promotes Oxidative‐Induced RPE Cell Death through Targeting FOXO1. BioMed Research International. 2021(1). 6666506–6666506. 14 indexed citations
14.
Ye, Peng, Donghui Yu, Ruiling Zhang, et al.. (2018). 17β-estradiol ameliorates oxidative stress and blue light-emitting diode-induced retinal degeneration by decreasing apoptosis and enhancing autophagy. Drug Design Development and Therapy. Volume 12. 2715–2730. 23 indexed citations
15.
Ren, Chengda, et al.. (2017). Circulating miRNAs as Potential Biomarkers of Age-Related Macular Degeneration. Cellular Physiology and Biochemistry. 41(4). 1413–1423. 46 indexed citations
16.
Liu, Qingyu, Junling Liu, Chengda Ren, et al.. (2017). Proteomic analysis of tears following acupuncture treatment for menopausal dry eye disease by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry. International Journal of Nanomedicine. Volume 12. 1663–1671. 38 indexed citations
17.
Liu, Qingyu, et al.. (2016). Short-term effects of orthokeratology on the development of low-to-moderate myopia in Chinese children. SHILAP Revista de lepidopterología. 2 indexed citations
18.
Liu, Qingyu, et al.. (2016). Effects of orthokeratology on the progression of low to moderate myopia in Chinese children. BMC Ophthalmology. 16(1). 126–126. 42 indexed citations
19.
Cai, Wenting, Qingyu Liu, Chengda Ren, et al.. (2016). Effect of bradykinin on TGF-β1-induced retinal pigment epithelial cell proliferation and extracellular matrix secretion. BMC Ophthalmology. 16(1). 199–199. 6 indexed citations
20.
Liu, Qingyu, Hui Shi, Junling Liu, et al.. (2015). Efficacy and safety of different doses of a slow-release corticosteroid implant for macular edema: meta-analysis of randomized controlled trials. Drug Design Development and Therapy. 9. 2527–2527. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Youn‐Shen Bee Breakdown of academic impact, for papers by Hiroki Tsujinaka Breakdown of academic impact, for papers by Huixia Wei Breakdown of academic impact, for papers by Yinghong Ji Breakdown of academic impact, for papers by Rayne R. Lim Breakdown of academic impact, for papers by Kairan Lai Breakdown of academic impact, for papers by Baoshan Huang Breakdown of academic impact, for papers by Dongqing Zhu Breakdown of academic impact, for papers by Chang Rae Rho Breakdown of academic impact, for papers by Tokuhiko Miki
Rankless by CCL
2026